Skip to content
PubMed This is a summary of 111 peer-reviewed journal articles Updated

Research & Literature

Explore the leading researchers and institutions driving advances in this area, and dive into the full body of literature that informs this resource.

Explore the Literature Visualize citation networks across 111 referenced papers

Top Authors

Darius Ebrahimi‐Fakhari
Boston Children's Hospital
Marcondes C. França
Universidade Estadual de Campinas (UNICAMP)
Rebecca Schüle
German Center for Neurodegenerative Diseases
Filippo Maria Santorelli
Fondazione Stella Maris
Jean‐Pierre Lin
Guy's and St Thomas' NHS Foundation Trust
Ludger J. Schöls
German Center for Neurodegenerative Diseases
Afshin Saffari
Boston Children's Hospital
Daniel Edward Lumsden
King's College London
Henry Houlden
UCL Queen Square Institute of Neurology
Stephan L. Zuchner
University of Miami

Top Institutions

Ranked by publications Top 10 institutions

References

References (111)
  1. 1

    Interventional studies in childhood dystonia do not address the concerns of children and their carers.

    Lumsden DE, Gimeno H, Tustin K, et al.

    European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society 2015; (19(3)):327-36.

    PMID: 25661063
  2. 2

    Childhood dystonias.

    Tabbal SD

    Current treatment options in neurology 2015; (17(3)):339 doi:10.1007/s11940-015-0339-4.

    PMID: 25704239
  3. 3

    Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

    Richards S, Aziz N, Bale S, et al.

    Genetics in medicine : official journal of the American College of Medical Genetics 2015; (17(5)):405-24 doi:10.1038/gim.2015.30.

    PMID: 25741868
  4. 4

    Truncating mutation in intracellular phospholipase A₁ gene (DDHD2) in hereditary spastic paraplegia with intellectual disability (SPG54).

    Alrayes N, Mohamoud HS, Jelani M, et al.

    BMC research notes 2015; (8()):271 doi:10.1186/s13104-015-1227-4.

    PMID: 26113134
  5. 5

    Gabapentin can significantly improve dystonia severity and quality of life in children.

    Liow NY, Gimeno H, Lumsden DE, et al.

    European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society 2016; (20(1)):100-7.

    PMID: 26455274
  6. 6

    Recessive Mutations in POLR3B Encoding RNA Polymerase III Subunit Causing Diffuse Hypomyelination in Patients with 4H Leukodystrophy with Polymicrogyria and Cataracts.

    Jurkiewicz E, Dunin-Wąsowicz D, Gieruszczak-Białek D, et al.

    Clinical neuroradiology 2017; (27(2)):213-220 doi:10.1007/s00062-015-0472-1.

    PMID: 26478204
  7. 7

    Hereditary spastic paraplegia: Clinicogenetic lessons from 608 patients.

    Schüle R, Wiethoff S, Martus P, et al.

    Annals of neurology 2016; (79(4)):646-58 doi:10.1002/ana.24611.

    PMID: 26856398
  8. 8

    Medication use in childhood dystonia.

    Lumsden DE, Kaminska M, Tomlin S, Lin JP

    European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society 2016; (20(4)):625-9.

    PMID: 26924167
  9. 9

    Motor neuron degeneration in spastic paraplegia 11 mimics amyotrophic lateral sclerosis lesions.

    Denora PS, Smets K, Zolfanelli F, et al.

    Brain : a journal of neurology 2016; (139(Pt 6)):1723-34 doi:10.1093/brain/aww061.

    PMID: 27016404
  10. 10

    Phenotypic insights into ADCY5-associated disease.

    Chang FC, Westenberger A, Dale RC, et al.

    Movement disorders : official journal of the Movement Disorder Society 2016; (31(7)):1033-40 doi:10.1002/mds.26598.

    PMID: 27061943
  11. 11

    Cerebral palsy.

    Graham HK, Rosenbaum P, Paneth N, et al.

    Nature reviews. Disease primers 2016; (2()):15082 doi:10.1038/nrdp.2015.82.

    PMID: 27188686
  12. 12

    Status dystonicus in childhood.

    Touati N, Ben Rhouma H, Kraoua I, et al.

    La Tunisie medicale 2015; (93(12)):756-9.

    PMID: 27249384
  13. 13

    CYP2U1 mutations in two Iranian patients with activity induced dystonia, motor regression and spastic paraplegia.

    Kariminejad A, Schöls L, Schüle R, et al.

    European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society 2016; (20(5)):782-7.

    PMID: 27292318
  14. 14

    Dopa-responsive dystonia in Chinese patients: Including a novel heterozygous mutation in the GCH1 gene with an intermediate phenotype and one case of prenatal diagnosis.

    Zhang W, Zhou Z, Li X, et al.

    Neuroscience letters 2017; (644()):48-54 doi:10.1016/j.neulet.2017.01.019.

    PMID: 28087438
  15. 15

    Hereditary spastic paraplegia: More than an upper motor neuron disease.

    Parodi L, Fenu S, Stevanin G, Durr A

    Revue neurologique 2017; (173(5)):352-360 doi:10.1016/j.neurol.2017.03.034.

    PMID: 28449883
  16. 16

    Dystonic storm: a practical clinical and video review.

    Termsarasab P, Frucht SJ

    Journal of clinical movement disorders 2017; (4()):10 doi:10.1186/s40734-017-0057-z.

    PMID: 28461905
  17. 17

    Pathophysiology, diagnostic work-up and management of balance impairments and falls in patients with hereditary spastic paraplegia.

    Nonnekes J, van Lith B, van de Warrenburg BP, et al.

    Journal of rehabilitation medicine 2017; (49(5)):369-377 doi:10.2340/16501977-2227.

    PMID: 28471471
  18. 18

    Clinical Management of Dystonia in Childhood.

    Luc QN, Querubin J

    Paediatric drugs 2017; (19(5)):447-461 doi:10.1007/s40272-017-0243-3.

    PMID: 28620849
  19. 19

    Spastic paraplegia type 4: A novel SPAST splice site donor mutation and expansion of the phenotype variability.

    Kawarai T, Montecchiani C, Miyamoto R, et al.

    Journal of the neurological sciences 2017; (380()):92-97 doi:10.1016/j.jns.2017.07.011.

    PMID: 28870597
  20. 20

    Rethinking status dystonicus.

    Ruiz-Lopez M, Fasano A

    Movement disorders : official journal of the Movement Disorder Society 2017; (32(12)):1667-1676 doi:10.1002/mds.27207.

    PMID: 29144565
  21. 21

    [Genetic aspects of movement disorders of adulthood].

    Horvath J, Ranza E

    Revue medicale suisse 2018; (14(604)):879-882.

    PMID: 29701433
  22. 22

    The Twists of Pediatric Dystonia: Phenomenology, Classification, and Genetics.

    Meijer IA, Pearson TS

    Seminars in pediatric neurology 2018; (25()):65-74 doi:10.1016/j.spen.2018.02.001.

    PMID: 29735118
  23. 23

    SPG11 mutations cause widespread white matter and basal ganglia abnormalities, but restricted cortical damage.

    Faber I, Martinez ARM, de Rezende TJR, et al.

    NeuroImage. Clinical 2018; (19()):848-857 doi:10.1016/j.nicl.2018.05.031.

    PMID: 29946510
  24. 24

    Alone in a Crowd? Parents of Children with Rare Diseases' Experiences of Navigating the Healthcare System.

    Baumbusch J, Mayer S, Sloan-Yip I

    Journal of genetic counseling 2018; doi:10.1007/s10897-018-0294-9.

    PMID: 30128673
  25. 25

    Motor and non-motor determinants of health-related quality of life in young dystonia patients.

    Eggink H, Coenen MA, de Jong R, et al.

    Parkinsonism & related disorders 2019; (58()):50-55 doi:10.1016/j.parkreldis.2018.08.008.

    PMID: 30181088
  26. 26

    Genetic landscape of pediatric movement disorders and management implications.

    Cordeiro D, Bullivant G, Siriwardena K, et al.

    Neurology. Genetics 2018; (4(5)):e265 doi:10.1212/NXG.0000000000000265.

    PMID: 30283815
  27. 27

    [Genetics of movement disorders-rare but important].

    Klebe S, Timmann D

    Der Nervenarzt 2019; (90(2)):197-210 doi:10.1007/s00115-018-0659-1.

    PMID: 30645659
  28. 28

    Mitochondrial complex I NUBPL mutations cause combined dystonia with bilateral striatal necrosis and cerebellar atrophy.

    Balint B, Charlesworth G, Stamelou M, et al.

    European journal of neurology 2019; (26(9)):1240-1243 doi:10.1111/ene.13956.

    PMID: 30897263
  29. 29

    Stumbling, struggling, and shame due to spasticity: a qualitative study of adult persons with hereditary spastic paraplegia.

    Kerstens HCJW, Satink T, Nijkrake MJ, et al.

    Disability and rehabilitation 2020; (42(26)):3744-3751 doi:10.1080/09638288.2019.1610084.

    PMID: 31079503
  30. 30

    FAHN/SPG35: a narrow phenotypic spectrum across disease classifications.

    Rattay TW, Lindig T, Baets J, et al.

    Brain : a journal of neurology 2019; (142(6)):1561-1572 doi:10.1093/brain/awz102.

    PMID: 31135052
  31. 31

    Frequency and phenotypic spectrum of KMT2B dystonia in childhood: A single-center cohort study.

    Carecchio M, Invernizzi F, Gonzàlez-Latapi P, et al.

    Movement disorders : official journal of the Movement Disorder Society 2019; (34(10)):1516-1527 doi:10.1002/mds.27771.

    PMID: 31216378
  32. 32

    Status dystonicus: management and prevention in children at high risk.

    Iodice A, Pisani F

    Acta bio-medica : Atenei Parmensis 2019; (90(3)):207-212 doi:10.23750/abm.v90i3.7207.

    PMID: 31580306
  33. 33

    Clinical diagnostic exome sequencing in dystonia: Genetic testing challenges for complex conditions.

    Powis Z, Towne MC, Hagman KDF, et al.

    Clinical genetics 2020; (97(2)):305-311 doi:10.1111/cge.13657.

    PMID: 31628766
  34. 34

    Non-motor symptoms are relevant and possibly treatable in hereditary spastic paraplegia type 4 (SPG4).

    Rattay TW, Boldt A, Völker M, et al.

    Journal of neurology 2020; (267(2)):369-379 doi:10.1007/s00415-019-09573-w.

    PMID: 31646384
  35. 35

    Ophthalmological changes in hereditary spastic paraplegia and other genetic diseases with spastic paraplegia.

    de Freitas JL, Rezende Filho FM, Sallum JMF, et al.

    Journal of the neurological sciences 2020; (409()):116620 doi:10.1016/j.jns.2019.116620.

    PMID: 31865189
  36. 36

    [A consensus on the standardization of the next generation sequencing process for the diagnosis of genetic diseases (4) - Report interpretation and genetic counseling].

    Huang H, Shen Y, Gu W, et al.

    Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics 2020; (37(3)):352-357 doi:10.3760/cma.j.issn.1003-9406.2020.03.022.

    PMID: 32128757
  37. 37

    Clinical Interpretation of Sequence Variants.

    Zhang J, Yao Y, He H, Shen J

    Current protocols in human genetics 2020; (106(1)):e98 doi:10.1002/cphg.98.

    PMID: 32176464
  38. 38

    Autosomal dominant GCH1 mutations causing spastic paraplegia at disease onset.

    Wassenberg T, Schouten MI, Helmich RC, et al.

    Parkinsonism & related disorders 2020; (74()):12-15 doi:10.1016/j.parkreldis.2020.03.019.

    PMID: 32278297
  39. 39

    Rhabdomyolysis.

    Cabral BMI, Edding SN, Portocarrero JP, Lerma EV

    Disease-a-month : DM 2020; (66(8)):101015 doi:10.1016/j.disamonth.2020.101015.

    PMID: 32532456
  40. 40

    A novel REEP1 splicing mutation with broad clinical variability in a family with hereditary spastic paraplegia.

    Park SY, Park JM, Lee B, et al.

    Gene 2021; (765()):145129 doi:10.1016/j.gene.2020.145129.

    PMID: 32905827
  41. 41

    Fifteen-minute consultation: Approach to investigation and management of childhood dystonia.

    Forman EB, King MD, Gorman KM

    Archives of disease in childhood. Education and practice edition 2021; (106(2)):71-77 doi:10.1136/archdischild-2019-318131.

    PMID: 32928841
  42. 42

    Defining the clinical, molecular and imaging spectrum of adaptor protein complex 4-associated hereditary spastic paraplegia.

    Ebrahimi-Fakhari D, Teinert J, Behne R, et al.

    Brain : a journal of neurology 2020; (143(10)):2929-2944 doi:10.1093/brain/awz307.

    PMID: 32979048
  43. 43

    Clinical Features of Acute Rhabdomyolysis in 55 Pediatric Patients.

    Yao Z, Yuan P, Hong S, et al.

    Frontiers in pediatrics 2020; (8()):539 doi:10.3389/fped.2020.00539.

    PMID: 33014933
  44. 44

    Monogenic variants in dystonia: an exome-wide sequencing study.

    Zech M, Jech R, Boesch S, et al.

    The Lancet. Neurology 2020; (19(11)):908-918 doi:10.1016/S1474-4422(20)30312-4.

    PMID: 33098801
  45. 45

    Status dystonicus associated with CLN8 disease.

    Yıldırım M, Köse E, Keçeli AM, et al.

    Brain & development 2021; (43(4)):571-575 doi:10.1016/j.braindev.2020.12.005.

    PMID: 33358637
  46. 46

    Variability in Cerebral Palsy Diagnosis.

    Aravamuthan BR, Fehlings D, Shetty S, et al.

    Pediatrics 2021; (147(2)) doi:10.1542/peds.2020-010066.

    PMID: 33402528
  47. 47

    Hereditary spastic paraplegia type 11: Clinicogenetic lessons from 339 patients.

    Du J

    Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia 2021; (85()):67-71 doi:10.1016/j.jocn.2020.11.036.

    PMID: 33581793
  48. 48

    GCH1 mutations in hereditary spastic paraplegia.

    Varghaei P, Yoon G, Estiar MA, et al.

    Clinical genetics 2021; (100(1)):51-58 doi:10.1111/cge.13955.

    PMID: 33713342
  49. 49

    Muscle Characteristics in Pediatric Hereditary Spastic Paraplegia vs. Bilateral Spastic Cerebral Palsy: An Exploratory Study.

    De Beukelaer N, Bar-On L, Hanssen B, et al.

    Frontiers in neurology 2021; (12()):635032 doi:10.3389/fneur.2021.635032.

    PMID: 33716937
  50. 50

    Scoring Algorithm-Based Genomic Testing in Dystonia: A Prospective Validation Study.

    Zech M, Jech R, Boesch S, et al.

    Movement disorders : official journal of the Movement Disorder Society 2021; (36(8)):1959-1964 doi:10.1002/mds.28614.

    PMID: 33949708
  51. 51

    Childhood-onset hereditary spastic paraplegia and its treatable mimics.

    Ebrahimi-Fakhari D, Saffari A, Pearl PL

    Molecular genetics and metabolism 2022; (137(4)):436-444 doi:10.1016/j.ymgme.2021.06.006.

    PMID: 34183250
  52. 52

    Rhabdomyolysis: Revisited.

    Gupta A, Thorson P, Penmatsa KR, Gupta P

    The Ulster medical journal 2021; (90(2)):61-69.

    PMID: 34276082
  53. 53

    Case Report: Guitarist's cramp as the initial manifestation of dopa-responsive dystonia with a novel heterozygous GCH1 mutation.

    Hasegawa T, Hosaka T, Harada R, et al.

    F1000Research 2021; (10()):361 doi:10.12688/f1000research.51433.1.

    PMID: 34394914
  54. 54

    Systematic Analysis of Brain MRI Findings in Adaptor Protein Complex 4-Associated Hereditary Spastic Paraplegia.

    Ebrahimi-Fakhari D, Alecu JE, Ziegler M, et al.

    Neurology 2021; (97(19)):e1942-e1954 doi:10.1212/WNL.0000000000012836.

    PMID: 34544818
  55. 55

    Clinical and molecular characterization of a large cohort of childhood onset hereditary spastic paraplegias.

    Giordani GM, Diniz F, Fussiger H, et al.

    Scientific reports 2021; (11(1)):22248 doi:10.1038/s41598-021-01635-2.

    PMID: 34782662
  56. 56

    Hereditary spastic paraplegia initially diagnosed as cerebral palsy.

    Suchowersky O, Ashtiani S, Au PB, et al.

    Clinical parkinsonism & related disorders 2021; (5()):100114 doi:10.1016/j.prdoa.2021.100114.

    PMID: 34816117
  57. 57

    A homozygous ABHD16A variant causes a complex hereditary spastic paraplegia with developmental delay, absent speech, and characteristic face.

    Miyake N, Silva S, Troncoso M, et al.

    Clinical genetics 2022; (101(3)):359-363 doi:10.1111/cge.14097.

    PMID: 34866177
  58. 58

    Infantile onset ascending hereditary spastic paralysis.

    Eltoum A, O'Rourke D, Sharif F

    BMJ case reports 2022; (15(1)) doi:10.1136/bcr-2020-240941.

    PMID: 35039335
  59. 59

    A Clinical and Integrated Genetic Study of Isolated and Combined Dystonia in Taiwan.

    Wu MC, Chang YY, Lan MY, et al.

    The Journal of molecular diagnostics : JMD 2022; (24(3)):262-273 doi:10.1016/j.jmoldx.2021.12.003.

    PMID: 35041927
  60. 60

    Status Dystonicus in Children: A Cross-Sectional Study and Review of Literature.

    Saini AG, Hassan I, Sharma K, et al.

    Journal of child neurology 2022; (37(6)):441-450 doi:10.1177/08830738221081593.

    PMID: 35253510
  61. 61

    The diagnostic journey of genetically defined neurodevelopmental disorders.

    Simon J, Hyde C, Saravanapandian V, et al.

    Journal of neurodevelopmental disorders 2022; (14(1)):27 doi:10.1186/s11689-022-09439-9.

    PMID: 35501684
  62. 62

    The diagnostic odyssey: insights from parents of children living with an undiagnosed condition.

    Bauskis A, Strange C, Molster C, Fisher C

    Orphanet journal of rare diseases 2022; (17(1)):233 doi:10.1186/s13023-022-02358-x.

    PMID: 35717227
  63. 63

    Early onset disease, anarthria, areflexia, and dystonia can be the distinctive features of SPG64, a very rare form of hereditary spastic paraplegias.

    Ölmez A, Çetin GO, Karaer K

    American journal of medical genetics. Part A 2022; (188(9)):2712-2717 doi:10.1002/ajmg.a.62878.

    PMID: 35758610
  64. 64

    Early-Onset and Severe Complex Hereditary Spastic Paraplegia Caused by De Novo Variants in SPAST.

    Mo A, Saffari A, Kellner M, et al.

    Movement disorders : official journal of the Movement Disorder Society 2022; (37(12)):2440-2446 doi:10.1002/mds.29225.

    PMID: 36103453
  65. 65

    Arginase 1 deficiency presenting as complicated hereditary spastic paraplegia.

    Freua F, Almeida MEC, Nóbrega PR, et al.

    Cold Spring Harbor molecular case studies 2022; doi:10.1101/mcs.a006232.

    PMID: 36180229
  66. 66

    A Practical Guide to Genetic Testing for Kidney Disorders of Unknown Etiology.

    Aron AW, Dahl NK, Besse W

    Kidney360 2022; (3(9)):1640-1651 doi:10.34067/KID.0007552021.

    PMID: 36245662
  67. 67

    The clinical and molecular spectrum of ZFYVE26-associated hereditary spastic paraplegia: SPG15.

    Saffari A, Kellner M, Jordan C, et al.

    Brain : a journal of neurology 2023; (146(5)):2003-2015 doi:10.1093/brain/awac391.

    PMID: 36315648
  68. 68

    Hereditary spastic paraplegia in Mali: epidemiological and clinical features.

    Diarra S, Coulibaly T, Dembélé K, et al.

    Acta neurologica Belgica 2023; (123(6)):2155-2165 doi:10.1007/s13760-022-02113-w.

    PMID: 36396882
  69. 69

    Movement disorders in hereditary spastic paraplegia (HSP): a systematic review and individual participant data meta-analysis.

    Fereshtehnejad SM, Saleh PA, Oliveira LM, et al.

    Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2023; (44(3)):947-959 doi:10.1007/s10072-022-06516-8.

    PMID: 36441344
  70. 70

    Dysarthria in hereditary spastic paraplegia type 4.

    Jacinto-Scudeiro LA, Rothe-Neves R, Dos Santos VB, et al.

    Clinics (Sao Paulo, Brazil) 2023; (78()):100128 doi:10.1016/j.clinsp.2022.100128.

    PMID: 36473366
  71. 71

    Neurosurgical management of elevated tone in childhood: interventions, indications and uncertainties.

    Lumsden DE

    Archives of disease in childhood 2023; (108(9)):703-708 doi:10.1136/archdischild-2020-320907.

    PMID: 36690424
  72. 72

    Arginase 1 Deficiency in Patients Initially Diagnosed with Hereditary Spastic Paraplegia.

    McNutt MC, Foreman N, Gotway G

    Movement disorders clinical practice 2023; (10(1)):109-114 doi:10.1002/mdc3.13612.

    PMID: 36698992
  73. 73

    Case report: Rhabdomyolysis in children in acute and chronic disease-a challenging condition in pediatric emergency medicine.

    Mand N, Donath C, Leonhardt A, et al.

    Frontiers in pediatrics 2023; (11()):1070465 doi:10.3389/fped.2023.1070465.

    PMID: 36969298
  74. 74

    MECP2 duplication syndrome initially misdiagnosed as cerebral palsy: a case report.

    Kim TY, Lee SJ, Kim KM, Cho SR

    The Journal of international medical research 2023; (51(3)):3000605231162452 doi:10.1177/03000605231162452.

    PMID: 36988314
  75. 75

    Transitional Care for Young People with Movement Disorders: Consensus-Based Recommendations from the MDS Task Force on Pediatrics.

    Pringsheim T, Batla A, Shalash A, et al.

    Movement disorders clinical practice 2023; (10(5)):748-755 doi:10.1002/mdc3.13728.

    PMID: 37205244
  76. 76

    Movement disorders in hereditary spastic paraplegias.

    Pedroso JL, Vale TC, Freitas JL, et al.

    Arquivos de neuro-psiquiatria 2023; (81(11)):1000-1007 doi:10.1055/s-0043-1777005.

    PMID: 38035585
  77. 77

    The therapeutic effects of physical treatment for patients with hereditary spastic paraplegia: a narrative review.

    Di Ludovico A, Ciarelli F, La Bella S, et al.

    Frontiers in neurology 2023; (14()):1292527 doi:10.3389/fneur.2023.1292527.

    PMID: 38093754
  78. 78

    A Retrospective Review of 18 Patients With Childhood-Onset Hereditary Spastic Paraplegia, Nine With Novel Variants.

    Kilic MA, Yildiz EP, Deniz A, et al.

    Pediatric neurology 2024; (152()):189-195 doi:10.1016/j.pediatrneurol.2024.01.005.

    PMID: 38301322
  79. 79

    Hereditary spastic paraparesis type 46 (SPG46): new GBA2 variants in a large Italian case series and review of the literature.

    Cioffi E, Coppola G, Musumeci O, et al.

    Neurogenetics 2024; (25(2)):51-67 doi:10.1007/s10048-024-00749-9.

    PMID: 38334933
  80. 80

    Whole exome sequencing in Serbian patients with hereditary spastic paraplegia.

    Brankovic M, Ivanovic V, Basta I, et al.

    Neurogenetics 2024; (25(3)):165-177 doi:10.1007/s10048-024-00755-x.

    PMID: 38499745
  81. 81

    Long-Term Globus Pallidus Internus Deep Brain Stimulation in Pediatric Non-Degenerative Dystonia: A Cohort Study and a Meta-Analysis.

    Duga V, Giossi R, Romito LM, et al.

    Movement disorders : official journal of the Movement Disorder Society 2024; (39(7)):1131-1144 doi:10.1002/mds.29815.

    PMID: 38646731
  82. 82

    Actigraph-based quantification of sleep in children with dystonia undergoing deep brain stimulation.

    Zhang F, Mithani K, Breitbart S, et al.

    Neurosurgical focus 2024; (56(6)):E17 doi:10.3171/2024.3.FOCUS2462.

    PMID: 38823060
  83. 83

    Comparison of The Results of Sponsored Genetic Testing Panels for Inherited Retinal Diseases.

    Bao YK, Situ BA, Runner M, et al.

    Journal of clinical medicine 2024; (13(11)) doi:10.3390/jcm13113118.

    PMID: 38892829
  84. 84

    Evolving understanding of CP phenotypes: the importance of dystonia.

    Lewis SA, Aravamuthan B, Fehlings D, Kruer MC

    Pediatric research 2024; doi:10.1038/s41390-024-03327-9.

    PMID: 38926549
  85. 85

    Combined genomics and proteomics unveils elusive variants and vast aetiologic heterogeneity in dystonia.

    Zech M, Dzinovic I, Skorvanek M, et al.

    Brain : a journal of neurology 2025; (148(8)):2827-2846 doi:10.1093/brain/awaf059.

    PMID: 39937650
  86. 86

    Eye movement disorders in genetic dystonia syndromes: A literature overview.

    Pollini L, Pettenuzzo I, Tijssen MAJ, et al.

    Parkinsonism & related disorders 2025; (133()):107325 doi:10.1016/j.parkreldis.2025.107325.

    PMID: 39966058
  87. 87

    Clinical and Basic Research on Dopa-Responsive Dystonia: Neuropathological and Neurochemical Findings.

    Furukawa Y

    Juntendo medical journal 2025; (71(1)):2-10 doi:10.14789/ejmj.JMJ24-0023-R.

    PMID: 40109402
  88. 88

    Spectrum of Inherited Childhood-Onset Dystonia: Case Series of 19 Families With Genotype and Phenotype Characterization Highlighting the Treatable Causes.

    Adarsha N, Shambhavi A, Sait H, et al.

    Clinical genetics 2025; (108(4)):422-432 doi:10.1111/cge.14762.

    PMID: 40302693
  89. 89

    French guidelines for the diagnosis and management of pure hereditary spastic paraplegia.

    Mania-Pâris L, Ewenczyk C, Nicolas G, et al.

    Revue neurologique 2025; (181(6)):471-482 doi:10.1016/j.neurol.2025.05.001.

    PMID: 40450402
  90. 90

    High Genetic Diagnostic Yield for Patients with Rare Movement Disorders at a Single-Center Neurogenetics Clinic.

    Penn D, Amir Y, David GB, et al.

    Movement disorders clinical practice 2025; (12(11)):1811-1820 doi:10.1002/mdc3.70145.

    PMID: 40470849
  91. 91

    Expanding the Phenotypic Spectrum of SPG4: Autism Spectrum Disorder in Early-Onset and Complex SPAST-HSP and Case Study.

    Quaranta CA, Gardani A, Andorno G, et al.

    Genes 2025; (16(8)) doi:10.3390/genes16080970.

    PMID: 40870017
  92. 92

    The cognitive profile of hereditary spastic paraplegia: a systematic review of the literature.

    Quinzi A, Capogna E, Guidi L, et al.

    Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2025; (46(12)):6393-6416 doi:10.1007/s10072-025-08408-z.

    PMID: 41032233
  93. 93

    Nonmotor Symptom Scales in Children With Movement Disorders: A Scoping Review.

    Desjardins C, Nilles C, Gimeno H, et al.

    Neurology 2025; (105(9)):e214289 doi:10.1212/WNL.0000000000214289.

    PMID: 41105901
  94. 94

    Health-Related Quality of Life in Rare Forms of Childhood-Onset Hereditary Spastic Paraplegia.

    Schmidt HJD, Battaglia N, Rong J, et al.

    Annals of clinical and translational neurology 2026; (13(1)):193-199 doi:10.1002/acn3.70244.

    PMID: 41199121
  95. 95

    Spectrum of Movement Disorders in Early-Onset Hereditary Spastic Paraplegia: A Study of 428 Cases.

    Resch D, Alecu JE, Yang K, et al.

    Movement disorders : official journal of the Movement Disorder Society 2026; (41(3)):615-624 doi:10.1002/mds.70141.

    PMID: 41328529
  96. 96

    Second Episode of Rhabdomyolysis: A Case Report.

    Ohns MJ, Wolfe B

    Journal of pediatric health care : official publication of National Association of Pediatric Nurse Associates & Practitioners 2026; (40(3)):e119-e124 doi:10.1016/j.pedhc.2025.11.027.

    PMID: 41474409
  97. 97

    French virtual multidisciplinary team meeting for pediatric movement disorders (PMD-vMDT): a three-year survey.

    François-Heude MC, Lecardonnel B, Papathanasiou M, et al.

    Frontiers in neurology 2025; (16()):1751665 doi:10.3389/fneur.2025.1751665.

    PMID: 41607847
  98. 98

    Diagnostic yield of genome sequencing in children with progressive movement disorders.

    Schierbaum L, Gonzalez Saez-Diez E, Tam A, et al.

    Brain : a journal of neurology 2026; (149(10)):3404-3413 doi:10.1093/brain/awag050.

    PMID: 41640354
  99. 99

    Rare and resilient: Longer-term experiences of families after genetic evaluation in the neonatal intensive care unit.

    Abouhala S, Del Rosario MC, Holm IA, Wojcik MH

    Genetics in medicine open 2026; (4()):103490 doi:10.1016/j.gimo.2025.103490.

    PMID: 41657716
  100. 100

    Genetic analysis reveals phenotypic variability in three Colombian families with dopa-responsive dystonia: novel genotype-phenotype correlations.

    Lince-Rivera I, Martinez-Córdoba N, Ramón-Gómez JL, et al.

    BMC medical genomics 2026; (19(1)).

    PMID: 41965601
  101. 101

    Tailoring acceptance and commitment therapy for parents of children with undiagnosed conditions: a qualitative pre-implementation study.

    Rutzick S, Aufox S, Borto E, et al.

    Orphanet journal of rare diseases 2026; (21(1)).

    PMID: 42069701
  102. 102

    Genotype-structure-phenotype correlations define divergent natural history in early-onset spastic paraplegia type 4.

    Alecu JE, Schierbaum LM, Tam A, et al.

    Brain : a journal of neurology 2026; doi:10.1093/brain/awag150.

    PMID: 42083457
  103. 103

    The genetic landscape of childhood-onset dystonia in a nationwide Turkish cohort: Clinical spectrum, molecular diagnostics, and therapeutic implications.

    Yilmaz S, Serdaroglu E, Simsek E, et al.

    European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society 2026; (62()):51-60 doi:10.1016/j.ejpn.2026.06.003.

    PMID: 42308683
  104. 104

    Familial White-Sutton Syndrome Caused by a Pathogenic POGZ p.Arg508* Variant: Intrafamilial Variability from Childhood to Adulthood.

    Chetta M, Lattarulo S, Stasi M, et al.

    Genes 2026; (17(6)) doi:10.3390/genes17060722.

    PMID: 42353881
  105. 105

    The expected utility and psychological impacts of exome sequencing results in the DDD-Africa study.

    Schnell S, Goliath Z, Shingwenyana B, et al.

    Journal of genetic counseling 2026; (35(3)):e70251 doi:10.1002/jgc4.70251.

    PMID: 42360085
  106. 106

    Clinical and genetic characteristics of pediatric hereditary spastic paraplegia in the Eastern Levant.

    Habanjar D, Kreidly S, Trad S, Boustany RM

    European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society 2026; (63()):69-75 doi:10.1016/j.ejpn.2026.07.003.

    PMID: 42462372
  107. 107

    Phenotypic Spectrum and Clinical Approach to Early-Onset Hereditary Spastic Paraplegia.

    Wilson JL, Blackstone C, Ebrahimi-Fakhari D, França Junior MC

    Movement disorders clinical practice 2026; doi:10.1002/mdc3.70827.

    PMID: 42764666
  108. 108

    Hereditary spastic paraplegia: a practical approach.

    Bradley M, Kalfat A, Walsh RA, et al.

    Practical neurology 2026; doi:10.1136/pn-2026-005344.

    PMID: 42816178
  109. 109

    Rehabilitation management of children with hereditary spastic paraplegia: a retrospective cohort study.

    Paget SP, McIntyre S, Lewis J, et al.

    Developmental neurorehabilitation 2026; 1-8 doi:10.1080/17518423.2026.2738682.

    PMID: 42831377
  110. 110

    Molecular Diagnostic Yield and Genotype-Phenotype Spectrum of Inherited Eye Diseases in a Tertiary Health Center in Türkiye.

    Çevik MÖ

    Beyoglu eye journal 2026; (11(3)):266-271 doi:10.14744/bej.2026.75391.

    PMID: 42898535
  111. 111

    Childhood-onset hereditary spastic paraplegia: at the crossroads between neurodevelopment and neurodegeneration.

    Espasandin-Hueter N, Salazar-Villacorta A, Escudero JM, et al.

    European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society 2026; (65()):50-65 doi:10.1016/j.ejpn.2026.10.002.

    PMID: 42976539